Chief Executive Officer
Mr. Hankin came to AMF as General Counsel in 2003, and was named CEO of AMF in 2007. He had previously held the position of Vice President of Business Affairs at Sony Pictures Entertainment. Mr. Hankin earned a B.A. in economics from the University of California, Los Angeles, and a J.D. from Vanderbilt University.
Senior Vice President, Business Development and General Counsel
Mr. Petrovich graduated from USC with a BS in Finance and received his JD from UCLA. He has over twenty years’ experience in private practice as a corporate finance lawyer and ten years of senior executive experience in biotech and biomedical companies, including serving as CEO of Calando Pharmaceuticals and Insert Therapeutics, both startups launched out of Caltech to develop cancer therapeutics.
Alfred Mann Foundation’s expertise collectively held by our engineering and development team is unparalleled in the medical device field. Working in a not-for-profit environment allows them the freedom to undertake seemingly impossible, risk-intensive projects that might be too costly or too risky for profit-driven companies. Among our employees we have many with doctorates and other advanced degrees, military veterans, and people who hail from more than 20 foreign countries and, between them, speak more than a dozen languages. Our diversity of background paired with a combined hundreds of years of experience in biomedical, mechanical and electrical engineering, quality control, software design, patent law and clinical expertise put us in a unique position to solve some of the most challenging problems in medicine and bring these products to patients who will benefit from them the most.
Meet some of our prolific inventors :
Throughout his career and during his time as the first President of AMF, Dr. Joe Schulman has applied his work as an engineer, physicist, and biologist to electronic design. He has more than 100 patents in biomedical technology and was instrumental in the development of the rechargeable cardiac pacemaker, the implantable insulin pump, and the first cochlear implant with bidirectional telemetry. Dr. Schulman now serves as the Chief Scientist at the Mann Medical Research Organization (MMRO). Born in New York City, Dr. Schulman grew up in Los Angeles and attended UCLA where he obtained a BS in Physics and a PhD in zoology.
Chuck Byers worked on the University of California, San Francisco team that ultimately implanted more than 20 cochlear implants in clinical trials before transferring the project to AMF. He designed and developed the hermetic case, the electrode array and lead, and the multichannel disconnect system associated with the cochlear implant. A listed inventor on more than three dozen US patents, Mr. Byers was also involved in the development of the microstimulator system and the long-term glucose sensor. Mr. Byers is a biomechanical engineer and earned his undergraduate degree at Brigham Young University.
Board of Directors